Skip to main content

Table 3 Operative and follow-up details

From: Salvage robot-assisted radical prostatectomy following focal ablation with irreversible electroporation: feasibility, oncological and functional outcomes

Prostate vol, median (mL) (IQR) 56 (43–70)
Index tumour vol, median (mL) (IQR) 0.75 (0.25–1)
Time between initial IRE ablation and sRARP (mo), median (IQR) 42 (21–57)
Nerve sparing, n (%)  
 Unilateral 6 (40%)
 Bilateral 9 (60%)
 None 0
Pelvic lymph node dissection, n (%) 4 (27%)
Gleason Grade/ISUP GGG after sRP, n (%) [Index Lesion]  
 3 + 3/1 0
 3 + 4/2 8 (53%)
 4 + 3/3 1 (7%)
 4 + 4/4 3 (20%)
 4 + 5/5 3 (20%)
Gleason Grade/ISUP GGG after sRP, n (%) [Composite]  
 3 + 3/1 0
 3 + 4/2 9 (60%)
 4 + 3/3 3 (20%)
 4 + 4/4 0
 4 + 5/5 3 (20%)
Surgical margin involvement, n (%) 1 (7%)
T stage, n (%)  
 pT2 9 (60%)
 pT3a 6 (40%)
 pT3b 0
Presence of cribriform pattern, n (%)  
 Yes 5 (33%)
 No 9 (67%)
Surgical complications, n (%) (rectal injury, cystotomy, ureteric injury) 0
Blood loss, mL, media (IQR) 200 (200–250)
Length of Stay, median 2 days
Follow-up (mo) since sRARP, median (IQR) 20 (15–30)
Postoperative RT, n (%) 0
Metastasis, n (%) 0
Continence, n (%)  
 Pad free after 3 months 14
 Pad free after 6 months 1
Incontinent 0
Erections, n (%)  
 Potent 5 (33%)
 Potent with PDE-5 inhibitor 4 (27%)
 Impotent 6 (40%)